BHP's Copper, Iron Ore Output Rose in Second Quarter 
 

The mining giant posted a sharp rise in second-quarter copper production thanks to a jump in output at Escondida, the world's largest copper mine.

 
Country Garden Shares Rise After Monthslong Suspension 
 

Shares in the company, once one of China's largest developers, rose on the resumption of trade after it pledged to reach a debt-restructuring deal with creditors.

 
Bain Capital in Talks to Buy Mitsubishi Tanabe Pharma 
 

Bain Capital is in talks to acquire Mitsubishi Chemical Group's pharmaceutical business in a potential multibillion-dollar deal, a person familiar with the matter said.

 
Olam Set to Announce Sale of Agribusiness Unit to Saudi Arabia Firm, Sources Say 
 

Singapore-based Olam Group is close to announcing a deal to sell the remainder of its stake in its agricultural products business to the state-owned Saudi Agricultural and Livestock Investment Company, people familiar with the situation said.

 
Costco Union Workers Vote to Authorize Strike Ahead of Contract Expiration 
 

Members have voted to authorize a strike in response to what the union said was the company's refusal to present a fair contract offer.

 
China Signals It Is Open to a Deal Keeping TikTok in U.S. 
 

The founder of the app's parent, Beijing-based ByteDance, met with Elon Musk last year.

 
KPMG Wants to Be the First Accounting Giant to Own a U.S. Law Firm. Here's Why. 
 

The bid in Arizona would break a barrier, potentially signaling deep changes for the accounting and legal industries.

 
It's a Tough Time for Builders. D.R. Horton's Outlook Could Be a Bright Spot. 
 

Horton's expectations for the spring homebuying season could be more important for builder stocks than quarterly earnings.

 
Schwab Earnings Will Give New CEO a Chance to Show His Stuff 
 

Investors are looking for insights into how the company intends to pay down short-term debt and rev up its growth engine in 2025.

 
Big Pharma, Beaten Down Under Biden, Hopes for New Chapter Under Trump 
 

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

(END) Dow Jones Newswires

January 21, 2025 01:00 ET (06:00 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.